New App 'Studio' Looks To Become Peloton For Runners
CEO and Founder of Studio Jason Baptiste and his new Director of Content and Programming Lisa Niren discuss their app and why it stands out from the crowd. They also explain why it's a better value than Peloton and other exercise apps.
Baptiste and Niren both believe the future of media is in subscription based content. Niren adds that the appeal of an app like Studio is being able to do it with others.
Baptiste says most members are in rural areas such as Iowa and Alaska, and Studio lets them engage in a class as if they're in the room. Baptiste also touches on Studio's own take on Bitcoin, "Fitcoin." Runners can accumulate Fitcoin and exchange it for real prizes.
Dana D’Auria, co-CIO at Envestnet, breaks down how she’s expecting markets to perform as ‘cracks’ from the rate hike cycle slowly filter into the economy.
A large cargo ship lost power and issued a mayday call moments before it struck the Francis Scott Key Bridge early Tuesday, though it was still moving toward the span at a rapid speed.
Candace Mitchell Harris discusses her path from computer scientist to founder of beauty tech tool MYAVANA – and how it uses A.I. to analyze each person’s unique haircare needs.
Michael Harris, NYSE global head of capital markets shares what to expect from IPOs in 2024, including A.I. excitement and why interest rate cuts are always helpful.
Lacy Garcia, Founder & CEO of Willow, shares why women, traditionally underserved by fintech, are looking for trust and a personal relationship from their financial advisor.
Alexander Reed, CFA and CIO for Envisage Wealth, breaks down why he thinks rates could stay higher for longer and why real estate, utilities, and regional banks are sectors to avoid.
Big brands that have relied on TikTok videos to reach younger consumers do not appear to be panicking as they wait to see what happens. But they have started planning.
It's been 15 years since the last fatal crash of a U.S. airliner, but you wouldn't know that from a torrent of flight problems that made news in the last three months.
Abortion opponents want the high court to ratify a ruling from a conservative federal appeals court that would limit access to a medication called mifepristone, which was used in nearly two-thirds of abortions last year.
